chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 24 Mar 2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 24 Mar 2022) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination. No Medical History information was reported. On 24-Mar-2022 at 3:19 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 24-Mar-2022 at 3:19 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 24 Mar 2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 24 Mar 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 24 Mar 2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 24 Mar 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not reported by the reporter. Patient received booster dose. Patient received Moderna vaccine past its 30 day of expiry date. Vaccine went into 2 to 8 degree Celsius thaw state on or about 24-Dec-2021. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. Treatment medications were not reported by the reporter.
This spontaneous report as received from a nurse via field representative refers to multiple unspecified patients of unknown age and gender. The nurse reported that multiple unspecified patients have come to her with concerned about GARDASIL due to reading unspecified Internet articles that claim multiple unspecified patients had died after receiving GARDASIL (lot#, dose and route not reported). The reporter stated the article was from "someone that claimed to be involved with the development of GARDASIL". The nurse did not have any patients that reported an adverse effect after receiving GARDASIL. The reporter stated "they got a call from the mother of a patient who just got GARDASIL who was crying and in hysterics on the phone because she had heard about all these side effects. This was happening on a daily basis". The reporter stated "I don't have any details about the article". Additional information is not expected.
Patient developed arm discomfort at site of injection for one month post administration. No medical treatment was sought. Patient took anti-inflammatory medication and used heat.
Pain in arm; Warm to the touch; Body aches mostly in lower body; Joint pain; Runny nose; Cough; Easily out of breath; Also brought back brain fog; Changes in taste; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 09:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome(IBS), migraine, COVID-19 and the patient had known allergies to decongestants, latex and several food allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levocetirizine dihydrochloride (XYZAL) from an unknown date for an unknown indication and unknown if ongoing. On 06Apr2021 at 17:00, the patient experienced pain in arm and warm to the touch, body aches mostly in lower body, joint pain, runny nose, cough and easily out of breath. The patient also felt brain fog and changes in taste. The patient started feeling bad that evening and felt as though she had COVID-19 again the day after vaccine and just tired with brain fog on the day after that. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain in arm and warm to the touch, body aches mostly in lower body, joint pain, runny nose, cough, easily out of breath, foggy feeling in head and taste changed were recovered on an unknown date in Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
On Friday July 16,Patient was wrongly administered 0.5ml of Pfizer Vaccine Intramuscular instead of 0.3ml by the Medical Reserve Corp Volunteer Vaccinator. Management was informed ,Incident report filed and patients are being notified by medical staff.
Low grade fever; Fatigue; Muscle aches; Discomfort at injection site; Headache; This is a spontaneous report received from a contactable consumer or other non-health care professional (patient). A 71-years-old non-pregnant female patient received unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6203), via an unspecified route of administration, administered in Arm Left on 23Feb2021 12:45 (at the age of 71-years-old) as dose number unknown, single for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD), allergy to metals (known allergies: Nickel) from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Concomitant medications included fluticasone propionate, salmeterol (WIXELA INHUB), tiotropium bromide (SPIRIVA), atorvastatin (ATORVASTATIN), albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]) taken for an unspecified indication, start and stop date were not reported. The patient experienced low grade fever, fatigue, muscle aches, discomfort at injection site, headache on 24Feb2021 08:00. No treatment was received for the events. The outcome of the events was reported as recovered in 2021.  No follow-up attempts are possible, information about lot/batch number cannot been obtained.
NAUSEA AFTER THIRD DOSE OF COVID VACCINE; SICK FROM COVID VACCINE; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (SICK FROM COVID VACCINE) and NAUSEA (NAUSEA AFTER THIRD DOSE OF COVID VACCINE) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Crohn's disease.    Previously administered products included for Drug use for unknown indication: STELARA. Past adverse reactions to the above products included No adverse event with STELARA. Concurrent medical conditions included Crohn's disease and Obsessive-compulsive disorder. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Obsessive-compulsive disorder.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Oct-2021, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram every two weeks. On 13-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Nov-2021, the patient experienced NAUSEA (NAUSEA AFTER THIRD DOSE OF COVID VACCINE). In November 2021, the patient experienced ILLNESS (SICK FROM COVID VACCINE). On 14-Nov-2021, NAUSEA (NAUSEA AFTER THIRD DOSE OF COVID VACCINE) had resolved. In November 2021, ILLNESS (SICK FROM COVID VACCINE) had resolved.            This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Treatment medications were not reported.  The reporter's causality for the event(s) of sick from covid vaccine and nausea after third dose of covid vaccine with Humira 40mg/0.4ml(adalimumab) was no reasonable possibility.
1. Aches/Pains muscular/joints  2. Slight fever with chills  3. Extreme Fatigue  4. Headache  5. Acute Tinnitus with hyperacusis
Hallucinations, high fever (reached 105), altered mental status, occurred about a week after the vaccination.
pt received moderna bivalent booster instead of moderna first dose, no adverse events, pt went to another pharmacy for 2nd dose and cdc was called and pharmacy was told the bivalent can count as primary dose, pt recieved second dose 1/27/23, no adverse events noted
Prolonged pain and stiffness at vaccination site (shoulder) for 3 weeks thus far.
Started feeling hot and sweaty with some dizziness. Laid down on cot and gave water to drink. Pulse ox=98, BP=110/72 and Pulse=78. She felt much better and left at 12:20pm.
Dose administered after 30-day use by date or after manufacturer date of expiry; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day use by date or after manufacturer date of expiry) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day use by date or after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day use by date or after manufacturer date of expiry) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported by the reporter.  Number of doses/vials were 168 doses.It was reported as unknown when the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions.  No treatment medications were reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: The follow-up received includes non-significant information.
I have Asthma; Very serious allergic reaction; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer unknown), for Covid-19 Immunization. The following information was reported: ASTHMA (non-serious), outcome "unknown", described as "I have Asthma"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Very serious allergic reaction".  Additional information: Patient want to know about the side effects, allergic side effects because patient had asthma. No death, no hospitalization but very serious allergic reaction.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt developed positive TB results. All family contacts were negative. Chest x-ray was negative.
Below vaccines were given at about 9:30am, pt woke from nap about 3pm with multiple large urticaria over back, lower extremities and abdomen (not at injection site).
Employer offered seasonal influenza vaccine administered at approx. 0800 on 09/29/11. End of work shift so was driving home when developed swelling of lips and tongue. Took OTC diphenhydramine and later went to urgent care where received, epinephrine, SOLUMEDROL & BENADRYL.
Severe pain in lower back 03/25 Low energy on 03/26 Temp 99.0, 99.4, 99.9 and headache on 03/27 Temp 99.4, 98.8  and headache on 03/28 Temp 99.4, 99.9 and headache and lower back pain on 03/29
nausea; arm pain; weakness in arms and legs; shortness of breath; Pale; Fell down and couldnt move; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (weakness in arms and legs), DYSPNOEA (shortness of breath), PALLOR (Pale), FALL (Fell down and couldnt move) and NAUSEA (nausea) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Neurological disorder NOS (has neurological condition that cause weakness in legs).   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced MUSCULAR WEAKNESS (weakness in arms and legs), DYSPNOEA (shortness of breath), PALLOR (Pale), FALL (Fell down and couldnt move) and VACCINATION SITE PAIN (arm pain). On 11-Feb-2021, the patient experienced NAUSEA (nausea). At the time of the report, MUSCULAR WEAKNESS (weakness in arms and legs), DYSPNOEA (shortness of breath), PALLOR (Pale), FALL (Fell down and couldnt move), NAUSEA (nausea) and VACCINATION SITE PAIN (arm pain) outcome was unknown.            Treatment information include tylenol, benadryl and Gatorade, which patient refused to take The outcome of events, arm pain, weakness in arms and legs, shortness of breath, pale, fell down and couldnt move, nausea was unknown.
Increased smell sensitivity,  leading to more frequent headaches, also phantom smells.  Tx was chiropractic care, which has previously helped with these headaches when they become more frequent. This has not helped, and many smells are more pungent and can lead to headaches more frequently even after treatment.  I also am smelling things that are not around, such as cigarette smoke in a personal vehicle that has not been smoked in or is anywhere near anyone who may currently be smoking. This is causing anxiety and waking up from sleep and am smelling things that are not present.
PT reported pain on left upper leg starting 02/28/19. Pain increased on 03/01/19. Rash on left leg started on Saturday 03/02/2019. PT was seen by PCP today 03/04/19 and was diagnosed with shingles.
This spontaneous report as received from a other health professional refers to a patient of unknown age and gender. The patients' pertinent medical history, current conditions and concomitant medications were not reported. On an unspecified date (reported as "between 09-SEP-2016 and 06-OCT-2016), the patient was vaccinated with improperly stored dose of VAQTA (dose and route were not reported) lot # M012261 and expiry date: 01-FEB-2018. The vaccine was exposed to temperature of 49 Fahrenheit for 30 minutes. No previous temperature excursion was reported. No adverse effects and no product quality complaint (PQC) was reported. No further information provided. This case was cross referenced with #1610USA004377, 1610USA003097 and 1610USA004376 (same reporter link). Additional information has been requested.
Headache/ head pressure, numbness right side of face and lips, panic attacks, extreme depression
31 year old female, after the vaccine administration refers to the nurse feeling pressure in the chest and difficulty swallowing and warmth in the eye are. Patient does not present difficulty in breathing, clear lungs not obstructed, intact skin, no edema in the airway visual inspection. Vital signs are taken, BP 120/80, P72, DXT 96MG/ DL, R 16. Consultation with Doctor is made, she indicates to keep patient under observation for 30 minutes. At 30 minutes, vitals are taken. P 70. BP 110/70, R16, Doctor indicates the patient can leave the vaccination center.
coughing up a phlegm, spitting up phlegm; body aches; headache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCTIVE COUGH (coughing up a phlegm, spitting up phlegm), PAIN (body aches), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D24M20A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN (body aches), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever). On an unknown date, the patient experienced PRODUCTIVE COUGH (coughing up a phlegm, spitting up phlegm). On 26-Feb-2021, PAIN (body aches), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) had resolved. At the time of the report, PRODUCTIVE COUGH (coughing up a phlegm, spitting up phlegm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medication included unspecified heart medication.  Treatment medications was not provided by the reporter
2 DAYS LATER WEAKNESS IN WALKING & ON DEC. 30, BEGAN AN ACUTE ILLNESS WITH FEVER, INCREASED HEART RATE,SEVERE GENERALIZED BODY PAINS. FEVER LASTED 2 WEEKS OR MORE. HR = 120 OFF & ON. DID NOT GO TO DOCTOR  UNTIL 8 DAYS LATER, SHE THINKS. LAB TEST DONE CRP WAS 75 & NV+ 0-4.9 2 WEEKS LATER WENT TO DR. AGAIN, MORE LAB CRP= 81.9 HAND FINGERS WERE VERY SWOLLEN AND STILL ARE. CONTINUE IN BOX 12.
Pt had shaking episode after hugging nanny-- the whole episode lasted 45 seconds.
Fatigue walking upstairs or uphill starting on second day after shot (if day of shot was day 1 then day 3), diarrhea started that afternoon continuing next day
after patient received the vaccine and resting in the chair, patient fainted and slid down a little in the chair, but his family member grabbed him and he regained consciousness immediately.  patient's vital signs appeared to be normal and no difficulty breathing, no injury. Patient could not explain why he fainted, he claimed felt a little weak. I let patient sat in the chair for another 15 to 20 minutes, patient appeared to be normal and not feeling weak. Then patient left pharmacy.
Per employee's incident report: "There is a temporal relationship between the and the onset of a right-sided brachial plexitis. This should result in minimum with a report to the CDC on adverse vaccine events. With luck, there will not be sequel, although there have been some medical expenses. I have not investigated with vaccine compensation act deals with this and do not think I should be responsible both to make that report and are not going to investigate whether I am entitled to compensation to cover my medical expenses, then I would appreciate being informed. I did ask others to make this report but had been told it was not already reported. There does not seem to be another place to write the symptoms and occurrence. It began 2 weeks after the event, I had no way of appreciating that the symptoms were accessible and were related to the vaccine which had been 2 weeks earlier. Thus when I called Dr. with the symptoms, he wanted an MRI before he saw me, then saw me the next day in office. He requested more MRI's a couple days later. He wanted follow with an EMG at the appropriate time 3 weeks after the onset of symptoms and then got a second opinion. I don't see how employee would have had the expertise in this and don't feel that I should contact employee health even when I pointed out there was a temporal relationship."
Got a headache immediately and a strange feeling all the way down my arm to my fingers. A health professional can to check my vitals ... every thing was fine, except for my blood pressure. As the day went on , my headache became more severe. I took one Advil upon arriving home , and another one at bed time.  The next day I felt fine except for pain all the way from my head to my feet on the right side of my body... my head , my jaw, my throat, arm , leg and foot. The next day the rest of the pain went away, except for my head and my eyes. My eyes feel like someone punched them. They still hurt , I have a headache and feel very tired.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A 5-year-old male patient received BNT162b2 (BNT162B2), on 07Apr2022 as dose 1, single (Lot number: FL9095) and on 29Apr2022 as dose 2, single (Lot number: FL8095) at the age of 5 years, all intramuscular for covid-19 immunisation; tetanus vaccine (TETANUS VACCINE), on 29Apr2022 (Batch/Lot number: unknown), in arm for immunisation. The patient's relevant medical history included: "known allergies: eggs" (unspecified if ongoing). Concomitant medication(s) included: POLIO. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 14Aug2022, outcome "recovering" and all described as "tested positive for covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (14Aug2022) positive. Therapeutic measures were not taken as a result of covid-19.
Had the flu vaccination on 10/27/00 and the next day, began experiencing body aches, low-grade fever, generalized malaise and lower back discomfort. These symptoms continued for 6 days.
4OCT92 fever all day; 5OCT92 fever to 104-sz-ER @ hosp-stroke-life lined to another hosp dx sepsis; p/25 days pt sent ot rehab; no rash;
Patient stated that arm was stiff and painful. Patient could not move arm well due to the stiffness and pain. No swelling or inject site redness.
With the first dose, only the sore arm was experienced.; This is a spontaneous report from a contactable consumer (patient). A 37-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL3247 and expiry date were not reported), via an unspecified route of administration, in the left arm on 23Feb2021 at 02:15 PM (age at the time of vaccination was 37-year-old), as dose 1, single for COVID-19 immunisation. The patient's medical history included HLAB27 associated anterior uveitis, exercise induced asthma, psoriasis and food allergy (kiwi), from an unknown date and unknown if ongoing Kiwi. Concomitant medications included norethindrone (NORETHISTERONE), fish oil, vitamin D3 and multivitamins taken for an unspecified indication, start and stop date were not reported. The patient was allergic to kiwi. The patient was not diagnosed with COVID-19 prior vaccination. The patient was not tested for COVID-19 post vaccination. The patient did not receive any vaccine prior to COVID-19 within four weeks. On 23Feb2021, the patient experienced sore arm. On 16Mar2021, the patient received second dose of BNT162B2. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Presented with myalgia/cough/generalized weakness.  Patient has been exposed 4 days ago with COVID. Found to be COVID-19+, admitted and tx w/O2, VitC, Zinc, steroids; family refused remdesivir; dc'd home w/O2.